Note 1 - Organization and Summary of Significant Accounting Policies (Details Textual)	1 Months Ended	3 Months Ended		12 Months Ended
	Apr. 30, 2019 shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($)	Sep. 30, 2022 USD ($)
Accounts Receivable, Allowance for Credit Loss, Ending Balance		$ 2,047		$ 36,980
Accounts Receivable, after Allowance for Credit Loss, Current, Total		265,477		273,451
Revenue, Remaining Performance Obligation, Amount		0
Contract with Customer, Asset, after Allowance for Credit Loss, Total		0
Federal Deposit Insurance Corporation Premium Expense				250,000
Cash, Uninsured Amount		2,700,000		$ 5,800,000
Net Income (Loss) Attributable to Parent, Total		(3,956,062)	$ (19,160,904)
Working Capital		$ 5,977,801
Customer Concentration Risk [Member] | Revenue, Segment Benchmark [Member]
Number of Major Customers		0
Manufacturing Equipment [Member]
Property, Plant and Equipment, Useful Life (Year)		5 years
Software [Member]
Property, Plant and Equipment, Useful Life (Year)		3 years
Minimum [Member]
MerchantProcessingFee		2.60%
Maximum [Member]
MerchantProcessingFee		5.00%
Cure Based Development, Llc [Member] | Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares	15,250,000
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)	5 years
Business Acquisition, Equity Interest Issued or Issuable, Number of Additional Earnout Shares (in shares) | shares	15,250,000
Cure Based Development, Llc [Member] | Unregistered Common Stock [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares	8,750,000	2,187,500
Business Acquisition, Equity Interest Issued or Issuable, Vesting Period (Year)	5 years